Lithuania vs Palestine, State of: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Lithuania
87.0%
in 2024
Palestine, State of
87.0%
in 2024
Lithuania rank
78th
Palestine, State of rank
78th
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Lithuania
- Palestine, State of
How they compare
Lithuania currently reports 87.0% against 87.0% in Palestine, State of, a difference of 0.0%.
Across all 9 years both countries report, Palestine, State of has been ahead every year.
Lithuania ranks 78th and Palestine, State of ranks 78th of 146 countries.
Palestine, State of has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lithuania | Palestine, State of | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 82.2% | 98.2% | 16.0% | Palestine, State of |
| 2020s | 83.0% | 93.2% | 10.2% | Palestine, State of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Lithuania or Palestine, State of?
- Lithuania, at 87.0% against 87.0% in Palestine, State of as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Lithuania and Palestine, State of?
- 0.0%, with Lithuania ahead.
- How many years of comparable data are there for Lithuania and Palestine, State of?
- 9 years are reported by both, from 2016 to 2024.
- How do Lithuania and Palestine, State of rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Lithuania ranks 78th and Palestine, State of ranks 78th of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.